|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ricard D, Idbaih A, Ducray F, Lahutte M,
Hoang-Xuan K and Delattre JY: Primary brain tumours in adults.
Lancet. 379:1984–1996. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Turkish Cancer Statistics Database:
(2015). Department of Cancer Turkish Ministry of Health, 2018
https://hsgm.saglik.gov.tr/tr/kanser-anasayfa
|
|
4
|
Republic of Turkey Ministry of Health
General Directorate of Public Health: Turkish Cancer Statistics
2015. http://www.hsgm.gov.tr.
|
|
5
|
Pinarbasi H, Silig Y and Gurelik M:
Genetic polymorphisms of GSTs and their association with primary
brain tumor incidence. Cancer Genet Cytogenet. 156:144–149.
2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rajaraman P, Melin BS, Wang Z,
McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins
RB, Wrensch M, et al: Genome-wide association study of glioma and
meta-analysis. Hum Genet. 131:1877–1888. 2012.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ishikawa K, Takenaga K, Akimoto M,
Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, Honma Y and Hayashi
J: ROS-generating mitochondrial DNA mutations can regulate tumor
cell metastasis. Science. 320:661–664. 2008.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kumar B, Koul S, Khandrika L, Meacham RB
and Koul HK: Oxidative stress is inherent in prostate cancer cells
and mediates aggressive phenotype. J Urol. 179 (4s):192–193.
2008.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Klaunig JE and Kamendulis LM: The role of
oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol.
44:239–267. 2004.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tudek B, Winczura A, Janik J, Siomek A,
Foksinski M and Oliński R: Involvement of oxidatively damaged DNA
and repair in cancer development and aging. Am J Transl Res.
2:254–284. 2010.PubMed/NCBI
|
|
11
|
Klaunig JE, Kamendulis LM and Hocevar BA:
Oxidative stress and oxidative damage in carcinogenesis. Toxicol
Pathol. 38:96–109. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rajaraman P, Hutchinson A, Rothman N,
Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Linet MS and
Inskip PD: Oxidative response gene polymorphisms and risk of adult
brain tumors. Neuro-oncol. 10:709–715. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bag A and Bag N: Target sequence
polymorphism of human manganese superoxide dismutase gene and its
association with cancer risk: A review. Cancer Epidemiol Biomarkers
Prev. 17:3298–3305. 2008.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tamimi RM, Hankinson SE, Spiegelman D,
Colditz GA and Hunter DJ: Manganese superoxide dismutase
polymorphism, plasma antioxidants, cigarette smoking, and risk of
breast cancer. Cancer Epidemiol Biomarkers Prev. 13:989–996.
2004.PubMed/NCBI
|
|
15
|
Wan XS, Devalaraja MN and St Clair DK:
Molecular structure and organization of the human manganese
superoxide dismutase gene. DNA Cell Biol. 13:1127–1136.
1994.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pourvali K, Abbasi M and Mottaghi A: Role
of superoxide dismutase 2 gene Ala16Val polymorphism and total
antioxidant capacity in diabetes and its complications. Avicenna J
Med Biotechnol. 8:48–56. 2016.PubMed/NCBI
|
|
17
|
Sutton A, Khoury H, Prip-Buus C, Cepanec
C, Pessayre D and Degoul F: The Ala16Val genetic dimorphism
modulates the import of human manganese superoxide dismutase into
rat liver mitochondria. Pharmacogenetics. 13:145–157.
2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Kinnula VL, Lehtonen S, Koistinen P, Kakko
S, Savolainen M, Kere J, Ollikainen V and Laitinen T: Two
functional variants of the superoxide dismutase genes in Finnish
families with asthma. Thorax. 59:116–119. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee SJ, Choi MG, Kim DS and Kim TW:
Manganese superoxide dismutase gene polymorphism (V16A) is
associated with stages of albuminuria in Korean type 2 diabetic
patients. Metabolism. 55:1–7. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zotova EV, Chistiakov DA, Savost'ianov KV,
Bursa TR, Galeev IV, Strokov IA and Nosikov VV: Association of the
SOD2 Ala(-9)Val and SOD3 Arg213Gly polymorphisms with diabetic
polyneuropathy in patients with diabetes mellitus type 1. Mol Biol
(Mosk). 37:404–408. 2003.(In Russian). PubMed/NCBI
|
|
21
|
Taufer M, Peres A, de Andrade VM, de
Oliveira G, Sá G, do Canto ME, dos Santos AR, Bauer ME and da Cruz
IB: Is the Val16Ala manganese superoxide dismutase polymorphism
associated with the aging process? J Gerontol A Biol Sci Med Sci.
60:432–438. 2005.PubMed/NCBI
|
|
22
|
Hiroi S, Harada H, Nishi H, Satoh M, Nagai
R and Kimura A: Polymorphisms in the SOD2 and HLA-DRB1 genes are
associated with nonfamilial idiopathic dilated cardiomyopathy in
Japanese. Biochem Biophys Res Commun. 261:332–339. 1999.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mitrunen K, Sillanpää P, Kataja V,
Eskelinen M, Kosma VM, Benhamou S, Uusitupa M and Hirvonen A:
Association between manganese superoxide dismutase (MnSOD) gene
polymorphism and breast cancer risk. Carcinogenesis. 22:827–829.
2001.PubMed/NCBI
|
|
24
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tas A, Atabey M, Caglayan G, Bostanci ME,
Sahin Bolukbasi S, Topcu O and Silig Y: Investigation of the
association between the MDM2 T309G polymorphism and gastric cancer.
Biomed Rep. 7:469–473. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zejnilovic J, Akev N, Yilmaz H and Isbir
T: Association between manganese superoxide dismutase polymorphism
and risk of lung cancer. Cancer Genet Cytogenet. 189:1–4.
2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fisher JL, Schwartzbaum JA, Wrensch M and
Wiemels JL: Epidemiology of brain tumors. Neurol Clin. 25:867–890,
vii. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
De Roos AJ, Rothman N, Inskip PD, Linet
MS, Shapiro WR, Selker RG, Fine HA, Black PM, Pittman GS and Bell
DA: Genetic polymorphisms in GSTM1, -P1, -T1, and CYP2E1 and the
risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev.
12:14–22. 2003.PubMed/NCBI
|
|
29
|
Gu J, Liu Y, Kyritsis AP and Bondy ML:
Molecular epidemiology of primary brain tumors. Neurotherapeutics.
6:427–435. 2009.PubMed/NCBI View Article : Google Scholar
|
|
30
|
American Brain Tumor Association: Brain
Tumor Primer - A Comprehensive Introduction to Brain Tumor. 9th
edition. ABT Press, 2012.
|
|
31
|
Sathornsumetee S and Rich JN: New
approaches to primary brain tumor treatment. Anticancer Drugs.
17:1003–1016. 2006.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Sun GG, Wang YD, Lu YF and Hu WN:
Different association of manganese superoxide dismutase gene
polymorphisms with risk of prostate, esophageal, and lung cancers:
Evidence from a meta-analysis of 20,025 subjects. Asian Pac J
Cancer Prev. 14:1937–1943. 2013.PubMed/NCBI
|
|
33
|
Shimoda-Matsubayashi S, Matsumine H,
Kobayashi T, Nakagawa-Hattori Y, Shimizu Y and Mizuno Y: Structural
dimorphism in the mitochondrial targeting sequence in the human
manganese superoxide dismutase gene. A predictive evidence for
conformational change to influence mitochondrial transport and a
study of allelic association in Parkinson's disease. Biochem
Biophys Res Commun. 226:561–565. 1996.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wang LI, Miller DP, Sai Y, Liu G, Su L,
Wain JC, Lynch TJ and Christiani DC: Manganese superoxide dismutase
alanine-to-valine polymorphism at codon 16 and lung cancer risk. J
Natl Cancer Inst. 93:1818–1821. 2001.PubMed/NCBI
|
|
35
|
Hung RJ, Boffetta P, Brennan P, Malaveille
C, Gelatti U, Placidi D, Carta A, Hautefeuille A and Porru S:
Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with
environmental exposures and bladder cancer risk. Carcinogenesis.
25:973–978. 2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ambrosone CB, Freudenheim JL, Thompson PA,
Bowman E, Vena JE, Marshall JR, Graham S, Laughlin R, Nemoto T and
Shields PG: Manganese superoxide dismutase (MnSOD) genetic
polymorphisms, dietary antioxidants, and risk of breast cancer.
Cancer Res. 59:602–606. 1999.PubMed/NCBI
|
|
37
|
Ergen HA, Narter F, Timirci O and Isbir T:
Effects of manganase superoxide dismutase Ala-9Val polymorphism on
prostate cancer: A case-control study. Anticancer Res.
27:1227–1230. 2007.PubMed/NCBI
|
|
38
|
Woodson K, Tangrea JA, Lehman TA, Modali
R, Taylor KM, Snyder K, Taylor PR, Virtamo J and Albanes D:
Manganese superoxide dismutase (MnSOD) polymorphism, α-tocopherol
supplementation and prostate cancer risk in the α-tocopherol,
beta-carotene cancer prevention study (Finland). Cancer Causes
Control. 14:513–518. 2003.PubMed/NCBI
|
|
39
|
Olson SH, Carlson MD, Ostrer H, Harlap S,
Stone A, Winters M and Ambrosone CB: Genetic variants in SOD2, MPO,
and NQO1, and risk of ovarian cancer. Gynecol Oncol. 93:615–620.
2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Rosenblum JS, Gilula NB and Lerner RA: On
signal sequence polymorphisms and diseases of distribution. Proc
Natl Acad Sci USA. 93:4471–4473. 1996.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liu Y, Zha L, Li B, Zhang L, Yu T and Li
L: Correlation between superoxide dismutase 1 and 2 polymorphisms
and susceptibility to oral squamous cell carcinoma. Exp Ther Med.
7:171–178. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Zhao P, Zhao L, Zou P, Lu A, Liu N, Yan W,
Kang C, Fu Z, You Y and Jiang T: Genetic oxidative stress variants
and glioma risk in a Chinese population: A hospital-based
case-control study. BMC Cancer. 12(617)2012.PubMed/NCBI View Article : Google Scholar
|
